Home>>Signaling Pathways>> GPCR/G protein>> Melatonin Receptors>>Agomelatine

Agomelatine Sale

(Synonyms: 阿戈美拉汀; S-20098) 目录号 : GC17981

Agomelatine是一种褪黑素(MT)受体激动剂,对MT1和MT2的Ki值分别为0.1 nM和0.12 nM。Agomelatine也是一种5-羟色胺(5-HT)受体拮抗剂,对5-HT2C 和5-HT2B 的Ki值分别为631 nM和660 nM。

Agomelatine Chemical Structure

Cas No.:138112-76-2

规格 价格 库存 购买数量
10mM (in 1mL DMSO)
¥441.00
现货
5mg
¥368.00
现货
10mg
¥546.00
现货
50mg
¥1,586.00
现货
100mg
¥2,300.00
现货

电话:400-920-5774 Email: sales@glpbio.cn

Customer Reviews

Based on customer reviews.

Sample solution is provided at 25 µL, 10mM.

产品文档

Quality Control & SDS

View current batch:

实验参考方法

Cell experiment [1]:

Cell lines

HUVEC cells

Preparation method

HUVECs were exposed to Ang II (1μM) with or without Agomelatine (10, 20 μM) for 24 h.

Reaction Conditions

10, 20 μM; 24 h

Applications

Introduction of 10 and 20μM Agomelatine prevented the increase in AT1R expression induced by exposure to Ang II, with the higher dose having a more robust inhibitory effect.

Animal experiment [2]:

Animal models

LPS-induced rat model of depression

Preparation method

Agomelatine was dissolved in 1% hydroxyethyl cellulose (HEC) solution. In all experiments, agomelatine (40mg/kg) was administered via an i.p. injection at 60 min prior to daily LPS procedures.

Dosage form

40mg/kg; i.p.

Applications

Agomelatine can reverse LPS-induced depression-like behavior in rats and reduce the neuroinflammatory response in the DG area of the brain.

References:

[1] Hong N, Ye Z, Lin Y, et al. Agomelatine prevents angiotensin II-induced endothelial and mononuclear cell adhesion[J]. Aging (albany NY), 2021, 13(14): 18515.

[2]Lan T, Wu Y, Zhang Y, et al. Agomelatine rescues lipopolysaccharide-induced neural injury and depression-like behaviors via suppression of the Gαi-2-PKA-ASK1 signaling pathway[J]. Journal of neuroinflammation, 2022, 19(1): 117.

产品描述

Agomelatine is a melatonin (MT) receptor agonist with Ki values of 0.1 nM and 0.12 nM for MT1 and MT2, respectively[1]. Agomelatine is also a 5-hydroxytryptamine (5-HT) receptor antagonist with Ki values of 631 nM and 660 nM for 5-HT2C and 5-HT2B respectively[2]. Agomelatine can regulate circadian rhythm and enhance mood, and is used in research on major depressive disorder (MDD) [3].

In vitro, Agomelatine (10, 20 μM) treated endothelial cells and monocytes for 24 h, dose-dependently inhibited the angiotensin II-induced increase in the expression of AT1R, VCAM-1 and ICAM-1 and reduced cell adhesion [4]. Agomelatine (8, 16 μM) treated hippocampal neuron HT22 cells for 24 hours, inhibited the neurotoxicity caused by cisplatin injury, and attenuated oxidative stress and inflammatory response [5].

In vivo, Agomelatine (40mg/kg) was treated by intraperitoneal injection in rats with LPS-induced depression and significantly improved the rats' anxiety and depression-like behaviors, reducing neuroinflammation and neuronal damage[6]. Agomelatine (25, 50 or 75 mg/kg; ip) has antioxidant activity in a mouse seizure model [7].

References:
[1] Dridi D, Zouiten A, Mansour H B. Depression: chronophysiology and chronotherapy[J]. Biological rhythm research, 2014, 45(1): 77-91.
[2] Millan M J, Gobert A, Lejeune F, et al. The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways[J]. Journal of Pharmacology and Experimental Therapeutics, 2003, 306(3): 954-964.
[3] Smeraldi E, Delmonte D. Agomelatine in depression[J]. Expert opinion on drug safety, 2013, 12(6): 873-880.
[4] Hong N, Ye Z, Lin Y, et al. Agomelatine prevents angiotensin II-induced endothelial and mononuclear cell adhesion[J]. Aging (albany NY), 2021, 13(14): 18515.
[5] Cankara F N, Günaydın C, Çelik Z B, et al. Agomelatine confers neuroprotection against cisplatin-induced hippocampal neurotoxicity[J]. Metabolic brain disease, 2021, 36(2): 339-349.
[6] Lan T, Wu Y, Zhang Y, et al. Agomelatine rescues lipopolysaccharide-induced neural injury and depression-like behaviors via suppression of the Gαi-2-PKA-ASK1 signaling pathway[J]. Journal of neuroinflammation, 2022, 19(1): 117.
[7] Aguiar C C T, Almeida A B, Araújo P V P, et al. Effects of agomelatine on oxidative stress in the brain of mice after chemically induced seizures[J]. Cellular and molecular neurobiology, 2013, 33: 825-835.

Agomelatine是一种褪黑素(MT)受体激动剂,对MT1和MT2的Ki值分别为0.1 nM和0.12 nM[1]。Agomelatine也是一种5-羟色胺(5-HT)受体拮抗剂,对5-HT2C 和5-HT2B 的Ki值分别为631 nM和660 nM[2]。Agomelatine可以调节昼夜节律和提升情绪,应用于重度抑郁症(MDD)研究[3]

在体外,Agomelatine(10、20μM)处理内皮细胞和单核细胞24h,剂量依赖性地抑制了血管紧张素II诱导的AT1R、VCAM-1和ICAM-1的表达增加,减少了细胞粘附[4]。Agomelatine(8、16μM)处理海马神经元HT22细胞24h,抑制了顺铂损伤引起的神经毒性,减弱了氧化应激和炎症反应[5]

在体内,Agomelatine(40mg/kg)通过腹膜注射治疗LPS诱导的抑郁症大鼠,显著改善了大鼠的焦虑和抑郁样行为,减轻了神经炎症和神经元损伤[6]。Agomelatine (25、50或75 mg/kg;ip) 在小鼠癫痫发作模型中具有抗氧化活性[7]

Chemical Properties

Cas No. 138112-76-2 SDF
别名 阿戈美拉汀; S-20098
化学名 N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide
Canonical SMILES CC(=O)NCCC1=CC=CC2=C1C=C(C=C2)OC
分子式 C15H17NO2 分子量 243.3
溶解度 ≥ 12.2mg/mL in DMSO 储存条件 Store at -20°C
General tips 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。
为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。
Shipping Condition 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。

溶解性数据

制备储备液
1 mg 5 mg 10 mg
1 mM 4.1102 mL 20.5508 mL 41.1015 mL
5 mM 0.822 mL 4.1102 mL 8.2203 mL
10 mM 0.411 mL 2.0551 mL 4.1102 mL
  • 摩尔浓度计算器

  • 稀释计算器

  • 分子量计算器

质量
=
浓度
x
体积
x
分子量
 
 
 
*在配置溶液时,请务必参考产品标签上、MSDS / COA(可在Glpbio的产品页面获得)批次特异的分子量使用本工具。

计算

动物体内配方计算器 (澄清溶液)

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
给药剂量 mg/kg 动物平均体重 g 每只动物给药体积 ul 动物数量
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方)
% DMSO % % Tween 80 % saline
计算重置